Creatinine-based and cystatin C-based GFR estimating equations and their non-GFR determinants in kidney transplant recipients

Clinical Journal of the American Society of Nephrology

Volumn 11, Issue 9, 2016, Pages 1640-1649

  Keddis, Mira T ^a   Amer, Hatem ^b   Voskoboev, Nikolay ^c   Kremers, Walter K ^d   Rule, Andrew D ^b,d   Lieske, John C ^b,c  

^a MAYO CLINIC   (United States)

^b Division of Nephrology and Hypertension   (United States)

^c Department of Laboratory Medicine and Pathology ^*  (United States)

^d MAYO CLINIC   (United States)

Author keywords

Cardiovascular Diseases; Creatinine; Cystatin C; Diabetes mellitus; Glomerular filtration rate; Iothalamic Acid; Kidney transplantation; Obesity; Proteinuria; Risk factors; Smoking; Triglycerides

Indexed keywords

CREATININE; CYSTATIN C; IOTALAMIC ACID; PREDNISONE; CONTRAST MEDIUM;

ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GLOMERULOPATHY; HEART MUSCLE INJURY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PROTEINURIA; ADULT; AGED; BLOOD; GLOMERULUS FILTRATION RATE; IMMUNOTURBIDIMETRY; KIDNEY; KIDNEY TRANSPLANTATION; MATHEMATICAL PHENOMENA; MIDDLE AGED; PHYSIOLOGY; RISK FACTOR;

ADULT; AGED; CONTRAST MEDIA; CREATININE; CROSS-SECTIONAL STUDIES; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOTURBIDIMETRY; IOTHALAMIC ACID; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MATHEMATICAL CONCEPTS; MIDDLE AGED; RISK FACTORS;

EID: 85021714719     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.11741115     Document Type: Article

References (40)

1. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F; Chronic Kidney Disease Epidemiology Collaboration: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247-254, 2006
2. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
3. Shaffi K, Uhlig K, Perrone RD, Ruthazer R, Rule A, Lieske JC, Navis G, Poggio ED, Inker LA, Levey AS: Performance of creatinine- based GFR estimating equations in solid-organ transplant recipients. Am J Kidney Dis 63: 1007-1018, 2014
4. Pöge U, Gerhardt T, Stoffel-Wagner B, Sauerbruch T,Woitas RP: Validation of the CKD-EPI formula in patients after renal transplantation. Nephrol Dial Transplant 26: 4104-4108, 2011
5. Buron F, Hadj-Aissa A, Dubourg L, Morelon E, Steghens JP, Ducher M, Fauvel JP: Estimating glomerular filtration rate in kidney transplant recipients: Performance over time of four creatinine-based formulas. Transplantation 92: 1005-1011, 2011
6. Kukla A, El-Shahawi Y, Leister E, Kasiske B, Mauer M, Matas A, Ibrahim HN: GFR-estimating models in kidney transplant recipients on a steroid-free regimen. Nephrol Dial Transplant 25: 1653-1661, 2010
7. Masson I, Flamant M, Maillard N, Rule AD, Vrtovsnik F, Peraldi MN, Thibaudin L, Cavalier E, Vidal-Petiot E, Bonneau C, Moranne O, Alamartine E, Mariat C, Delanaye P: MDRD versus CKD-EPI equation to estimate glomerular filtration rate in kidney transplant recipients. Transplantation 95: 1211-1217, 2013
8. Rule AD, Bailey KR, Schwartz GL, Khosla S, Lieske JC, Melton LJ 3rd: For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int 75: 1071-1078, 2009
9. Mathisen UD, Melsom T, Ingebretsen OC, Jenssen T, Njølstad I, Solbu MD, Toft I, Eriksen BO: Estimated GFR associates with cardiovascular risk factors independently of measuredGFR. J Am Soc Nephrol 22: 927-937, 2011
10. Hsu CY, Propert K, Xie D, Hamm L, He J, Miller E, Ojo A, Shlipak M, Teal V, Townsend R, Weir M, Wilson J, Feldman H; CRIC Investigators:Measured GFR does not outperform estimated GFR in predicting CKD-related complications. J Am Soc Nephrol 22:1931-1937, 2011
11. Laterza OF, Price CP, Scott MG: Cystatin C: An improved estimator of glomerular filtration rate? Clin Chem 48: 699-707, 2002
12. Vinge E, Lindergård B, Nilsson-Ehle P, Grubb A: Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest 59: 587-592, 1999
13. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD-EPI Investigators: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20-29, 2012
14. Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT; CKDPrognosis Consortium: Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 369: 932-943, 2013
15. Menon V, Shlipak MG, Wang X, Coresh J, Greene T, Stevens L, Kusek JW, Beck GJ, Collins AJ, Levey AS, Sarnak MJ: Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med 147: 19-27, 2007
16. Peralta CA, Katz R, Sarnak MJ, Ix J, Fried LF, De Boer I, PalmasW, Siscovick D, Levey AS, Shlipak MG: Cystatin C identifies chronic kidney disease patients at higher risk for complications. J AmSoc Nephrol 22: 147-155, 2011
17. WuCK, Lin JW, Caffrey JL, Chang MH, Hwang JJ, Lin YS: Cystatin C and long-term mortality among subjects with normal creatininebased estimated glomerular filtration rates: NHANES III (Third National Health and Nutrition Examination Survey). J AmColl Cardiol 56: 1930-1936, 2010
18. BhavsarNA, Appel LJ, Kusek JW, ContrerasG, Bakris G, Coresh J, Astor BC; AASK Study Group: Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. Am J Kidney Dis 58: 886-893, 2011
19. Rule AD, Bailey KR, Lieske JC, Peyser PA, Turner ST: Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associatedwith chronic kidney disease. Kidney Int 83: 1169-1176, 2013
20. Lafarge JC, Naour N, Clément K,Guerre-Millo M: Cathepsins and cystatin C in atherosclerosis and obesity. Biochimie 92: 1580-1586, 2010
21. Staun-Ram E, Miller A: Cathepsins (S and B) and their inhibitor Cystatin C in immune cells: Modulation by interferon-b and role played in cell migration. J Neuroimmunol 232: 200-206, 2011
22. NaourN, Fellahi S, Renucci JF, Poitou C, Rouault C, Basdevant A, Dutour A, Alessi MC, Bastard JP, Clément K, Guerre-Millo M: Potential contribution of adipose tissue to elevated serum cystatin C in human obesity. Obesity (Silver Spring) 17: 2121-2126, 2009
23. Melsom T, Fuskevåg OM, Mathisen UD, Strand H, Schei J, Jenssen T, Solbu M, Eriksen BO: Estimated GFR is biased by nontraditional cardiovascular risk factors. Am J Nephrol 41: 7-15, 2015
24. Wilson DM, Bergert JH, Larson TS, Liedtke RR: GFR determined by nonradiolabeled iothalamate using capillary electrophoresis. Am J Kidney Dis 30: 646-652, 1997
25. Meeusen JW, Rule AD, Voskoboev N, Baumann NA, Lieske JC: Performance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics. Clin Chem 61: 1265-1272, 2015
26. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G: Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67: 2089-2100, 2005
27. Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, LevyD, Fox CS: Overweight, obesity, and the development of stage 3 CKD: The Framingham Heart Study. Am J Kidney Dis 52: 39-48, 2008
28. Ejerblad E, Fored CM, Lindblad P, Fryzek J,McLaughlin JK, Nyrén O: Obesity and risk for chronic renal failure. J Am Soc Nephrol 17: 1695-1702, 2006
29. van Ree RM, Gross S, Zelle DM, van der Heide JJ, Schouten JP, van Son WJ, Gans RO, Bakker SJ: Influence of C-reactive protein and urinary protein excretion on prediction of graft failure and mortality by serum albumin in renal transplant recipients. Transplantation 89: 1247-1254, 2010
30. Rigatto C, Parfrey P, Foley R, Negrijn C, Tribula C, Jeffery J:Congestive heart failure in renal transplant recipients: Risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol 13: 1084-1090, 2002
31. Rigatto C, Foley R, Jeffery J, Negrijn C, Tribula C, Parfrey P:Electrocardiographic left ventricular hypertrophy in renal transplant recipients: Prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol 14: 462-468, 2003
32. Keddis MT, El-Zoghby ZM, El Ters M, Rodrigo E, Pellikka PA, Jaffe AS, Cosio FG: Cardiac troponin T before and after kidney transplantation:Determinants and implications for posttransplant survival. Am J Transplant 13: 406-414, 2013
33. Hickson LJ, Cosio FG, El-Zoghby ZM, Gloor JM, Kremers WK, Stegall MD, Griffin MD, Jaffe AS: Survival of patients on the kidney transplant wait list: Relationship to cardiac troponin T.Am J Transplant 8: 2352-2359, 2008
34. Apple FS, Murakami MM, Pearce LA, Herzog CA: Predictive value of cardiac troponin I and T for subsequent death in endstage renal disease. Circulation 106: 2941-2945, 2002
35. Anastasio P, Cirillo M, Spitali L, Frangiosa A, Pollastro RM, De Santo NG: Level of hydration and renal function in healthy humans. Kidney Int 60: 748-756, 2001
36. Delanaye P, Pieroni L, Abshoff C, Lutteri L,Chapelle JP, Krzesinski JM, Hainque B, Cavalier E: Analytical study of three cystatin C assays and their impact on cystatin C-based GFR-prediction equations. Clin Chim Acta 398: 118-124, 2008
37. Harman G, Akbari A, Hiremath S, White CA, Ramsay T, Kokolo MB, Craig J, Knoll GA: Accuracy of cystatin C-based estimates of glomerular filtration rate in kidney transplant recipients: A systematic review. Nephrol Dial Transplant 28: 741-757, 2013
38. Le Bricon T, Thervet E, Froissart M, Benlakehal M, Bousquet B, Legendre C, Erlich D: Plasma cystatin C is superior to 24-h creatinine clearance and plasma creatinine for estimation of glomerular filtration rate 3 months after kidney transplantation. Clin Chem 46: 1206-1207, 2000
39. Masson I, Maillard N, Tack I, Thibaudin L, Dubourg L, Delanaye P, Cavalier E, Bonneau C, Kamar N, Morelon E, Moranne O, Alamartine E, Mariat C: GFR estimation using standardized cystatin C in kidney transplant recipients. Am J Kidney Dis 61: 279-284, 2013
40. Masson I, Maillard N, Cavalier E, Alamartine E, Mariat C, Delanaye P: KDIGOguidelines and kidney transplantation: Is the cystatin-c based recommendation relevant? Am J Transplant 15:2211-2214, 2015